Subthreshold micropulse diode laser treatment in diabetic macular oedema
about
Laser photocoagulation for diabetic macular oedemaSublethal Photothermal Stimulation with a Micropulse Laser Induces Heat Shock Protein Expression in ARPE-19 Cells.Recent developments in laser treatment of diabetic retinopathyEvolution of retinal laser therapy: minimum intensity photocoagulation (MIP). Can the laser heal the retina without harming it?Micropulse and continuous wave diode retinal photocoagulation: visible and subvisible lesion parametersRelationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy.Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathyOptical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edemaSCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusionQuantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degenerationMüller cell activation, proliferation and migration following laser injuryFunctional outcome of subthreshold versus threshold diode laser photocoagulation in diabetic macular oedema.Long-term therapeutic efficacy of the subthreshold micropulse diode laser photocoagulation for diabetic macular edema.Subthreshold diode laser micropulse photocoagulation for the treatment of diabetic macular edema.Subthreshold Micropulse Photocoagulation for Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion including Best-Corrected Visual Acuity Greater Than 20/40The short-term efficacy of subthreshold Micropulse yellow (577-nm) laser photocoagulation for diabetic macular edema.Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review.Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy.Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema.Efficacy of subthreshold micropulse laser in the treatment of diabetic macular edema is influenced by pre-treatment central foveal thickness.Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis)Retinal light toxicitySubthreshold diode-laser micropulse photocoagulation as a primary and secondary line of treatment in management of diabetic macular edemaRandomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema.Comparative efficacy of pure yellow (577-nm) and 810-nm subthreshold micropulse laser photocoagulation combined with yellow (561-577-nm) direct photocoagulation for diabetic macular edema.Relationship between Outer Retinal Layers Thickness and Visual Acuity in Diabetic Macular Edema.Subthreshold Diode Micropulse Laser: A Review.Short-pulse duration retinal lasers: a review.Morphologic changes in the retina after selective retina therapy.Biological Modulation of Mouse RPE Cells in Response to Subthreshold Diode Micropulse Laser Treatment.Sub-threshold micro-pulse diode laser treatment in diabetic macular edema: A Meta-analysis of randomized controlled trials.Intravitreal Conbercept Injection with and without Grid Laser Photocoagulation in the Treatment of Diffuse Diabetic Macular Edema in Real-Life Clinical PracticeA Review of Subthreshold Micropulse Laser and Recent Advances in Retinal Laser Technology.A Review of Subthreshold Micropulse Laser for Treatment of Macular DisordersIntravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up.Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea.Diabetic macular edema: what is focal and what is diffuse?Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.A Quantitative Approach to Predict Differential Effects of Anti-VEGF Treatment on Diffuse and Focal Leakage in Patients with Diabetic Macular Edema: A Pilot Study
P2860
Q24202632-239C482B-774D-48B0-B009-CB3A337FD1B1Q27315036-14607160-A59D-476A-AAAB-7A0A7795D8BAQ28084139-4A767279-039D-4B37-8B46-230D9452BAFBQ33209758-B4D1FBEC-D184-449C-A026-6A957FCD3410Q33236165-6EBCBAAA-B86A-4FFA-B1F9-98E4E0FDE74DQ33264487-F85B9596-A08F-4262-A91D-F01D0D50FA6DQ33273239-5FD1311C-BDE2-482A-9862-1D2AFFFF2E10Q33320901-8FACE13B-BB59-4417-95EA-DA47F577381FQ33357187-66BB4710-AF98-43CF-AFBB-08FAF9782D94Q33402708-F888F22A-C584-49E6-BC8F-D5F29374EDBFQ33402860-6FC2F598-7A50-4A9B-B5D5-ECCCB65A225AQ33505318-9C9DE3F1-9D4C-410A-A5C0-7AE64B655594Q33568530-5E6B7FB4-B340-4865-8BEF-7C2CA118658CQ33925407-2A8E2F42-5641-411F-A956-87DCDDAA9122Q34190128-F08CDFB8-849A-4AE3-A840-EA79035C9598Q34206455-B2DF6220-BE42-4FB8-8A7B-4B2A3558EEDCQ34263219-EF3A183D-6516-4134-83EA-F01A9A9B7CF8Q34269588-8DDE9698-E662-47D1-80BA-C3004D1F94ADQ34439672-844ABE6A-3A81-4E4B-91BA-8BCB43839A8EQ34492289-094E20AD-C83D-4DA6-BBEA-CC64315C5C1AQ34718520-38C7BF44-981D-4105-8ACB-434813785CF8Q35016867-71DC01DA-70B1-4B50-88A5-E8E4BEE51BB5Q35130887-4247DD61-7E4A-4417-99D5-43F117133266Q35147159-171700A9-7CFD-47C3-9A76-FB184456EBCFQ35196889-471AF83F-F333-47AF-83D5-4A00CDD7A41CQ35416180-713BB093-8B85-4262-A3EB-A1E883F8D766Q35763701-71D0D86A-6FAC-4C4B-BC95-F7DC83EB67D5Q35950863-58B7A8E0-6987-4A47-BBFF-A8B91C7F780DQ35984112-539F2E9D-6F4C-47EB-91AC-136FAADEA072Q35991978-22ABC41F-FBA7-4134-BFCB-E56124DDEFA8Q36063372-68DFDC11-79AA-49FA-8964-4A30D3693C50Q36097239-70ACFA97-A73B-4D43-8D17-6FD0B009A35BQ36173627-7B6FC1EF-0B96-4B9A-902C-095B923F62F6Q36276337-4F42B65C-1BBC-4384-84E4-628C03B76962Q36379671-9CEB0432-AE1A-4363-9477-408393A920F7Q36856905-564B403D-846D-4F64-B999-B0EAAB4776B4Q36949135-240188C2-43E1-46E1-8E47-A0B28E67EDCCQ37261743-61375832-C680-45D2-9E01-7F5293BB3042Q37477129-DD51B1FB-9903-4FEB-82C6-560DE0D84ED7Q37731896-A4309658-D07E-42BB-9CFD-D60F47C5A035
P2860
Subthreshold micropulse diode laser treatment in diabetic macular oedema
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Subthreshold micropulse diode laser treatment in diabetic macular oedema
@ast
Subthreshold micropulse diode laser treatment in diabetic macular oedema
@en
type
label
Subthreshold micropulse diode laser treatment in diabetic macular oedema
@ast
Subthreshold micropulse diode laser treatment in diabetic macular oedema
@en
prefLabel
Subthreshold micropulse diode laser treatment in diabetic macular oedema
@ast
Subthreshold micropulse diode laser treatment in diabetic macular oedema
@en
P2093
P2860
P356
P1476
Subthreshold micropulse diode laser treatment in diabetic macular oedema
@en
P2093
A K Sjoelie
M L Laursen
P2860
P304
P356
10.1136/BJO.2003.040949
P407
P577
2004-09-01T00:00:00Z